Trials / Completed
CompletedNCT03110874
Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control
A Multi-center, Randomized, Interventional, Open, Phase Ⅳ Clinical Trial on Education Method of Fluterol® Inhalation Capsule 250/50 μg Inhaler for Asthma Control in Patients With Partly Controlled Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, randomized, open, non-inferiority, Phase 4 study
Detailed description
A Multi-center, Randomized, Interventional, Open, Phase Ⅳ Clinical Trial on Education Method of Fluterol® Inhalation Capsule 250/50 μg Inhaler for Asthma Control in Patients with Partly Controlled Asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | one-way education | 'Fluterol Inhalation Capsule(fluticasone propionate 250 μg, salmeterol xinafoate 72.5 μg) : one-way education' |
| DRUG | two-way education | 'Fluterol Inhalation Capsule(fluticasone propionate 250 μg, salmeterol xinafoate 72.5 μg) : two-way education' |
Timeline
- Start date
- 2015-10-08
- Primary completion
- 2016-09-01
- Completion
- 2017-05-10
- First posted
- 2017-04-12
- Last updated
- 2018-02-23
Source: ClinicalTrials.gov record NCT03110874. Inclusion in this directory is not an endorsement.